Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 5670 [2020-01809]

Download as PDF 5670 Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices approach if it satisfies the requirements of the applicable statutes and regulations. II. Paperwork Reduction Act of 1995 This draft guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3521). The collections of information in 21 CFR 601.12 and Form FDA 356h have been approved under OMB control number 0910–0338; the collections of information in 21 CFR parts 610 and 630 have been approved under OMB control numbers 0910– 0116. III. Electronic Access Persons with access to the internet may obtain the draft guidance at either https://www.fda.gov/vaccines-bloodbiologics/guidance-complianceregulatory-information-biologics/ biologics-guidances or https:// www.regulations.gov. Dated: January 27, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–01815 Filed 1–30–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Centers for Disease Control and Prevention (CDC)/ HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC can be found at https:// www.cdc.gov/maso/facm/facm CHACHSPT.html. DATES: March 5, 2020, 3:00 p.m.—4:00 p.m. Eastern Time (ET). ADDRESSES: This meeting will be held by webinar and will accommodate up to 100 attendees. To access the virtual meeting, please use the information below. jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:16 Jan 30, 2020 Jkt 250001 • Webinar link: https:// hrsa.connectsolutions.com/chac_ business_meeting/ • Conference call-in number: Æ Call in: 888–790–1964. Æ Passcode: 1251991. and phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Division of the Executive Secretariat. [FR Doc. 2020–01809 Filed 1–30–20; 8:45 am] BILLING CODE 4165–15–P FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Public Health Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301–443–5807; or CHACAdvisoryComm@hrsa.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES CHAC was established under Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as amended. The purpose of CHAC is to advise the Secretary of HHS, the Director of CDC, and the HRSA Administrator regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STDs; prevention and treatment efforts including surveillance of HIV infection, viral hepatitis, other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional eduction, patient healthcare delivery, and prevention services; agency policies about prevention of HIV, viral hepatitis and other STDs; treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the agencies in their developoment of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. During the March 5, 2020, meeting, CHAC will discuss issues related to a CDC pilot on recency assay-based incidence estimation and the President’s initiative on ‘‘Ending the HIV Epidemic: A Plan for America.’’ Agenda items are subject to change as priorities dictate. Due to the nature and time limitations of the meeting, members of the public will not have an opportunity to provide oral comments, although written comments may be submitted prior to the meeting, or up to 5 business days after the meeting, to Theresa Jumento at the contact information listed above. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Theresa Jumento at the address National Advisory Committee on Rural Health and Human Services SUPPLEMENTARY INFORMATION: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Health Resources and Services Administration Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary’s National Advisory Committee on Rural Health and Human Services (NACRHHS) has scheduled a public meeting. Information about NACRHHS and the agenda for this meeting can be found on the NACRHHS website at https://www.hrsa.gov/advisorycommittees/rural-health/index.html. DATES: March 2, 2020, 8:30 a.m.–5:15 p.m. Eastern Time (ET); March 3, 2020, 8:30 a.m.–5:15 p.m. ET; and March 4, 2020, 8:30 a.m.–11:15 a.m. ET. ADDRESSES: The address for the meeting is the Center for Disease Control and Prevention (CDC) Global Communications Center (GCC) Auditorium B3, 1600 Clifton Road, Atlanta, GA 30329. On the morning of March 3, 2020, NACRHHS will break into subcommittees. One subcommittee will travel to Mercer School of Medicine, 1550 College St., Macon, GA 31207. The other subcommittee will travel to Health Services Center, 608 Martin Luther King Drive, Hobson City, AL 36201. In the afternoon, at approximately 4:00 p.m. ET., NACRHHS will reconvene at the CDC GCC. FOR FURTHER INFORMATION CONTACT: Steven Hirsch, Administrative Coordinator at the Federal Office of Rural Health Policy, HRSA, 5600 Fishers Lane, 17W59D, Rockville, Maryland 20857; 301–443–7322; or shirsch@hrsa.gov. SUPPLEMENTARY INFORMATION: NACRHHS provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning both rural health and rural human services. SUMMARY: E:\FR\FM\31JAN1.SGM 31JAN1

Agencies

[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Page 5670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01809]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Centers for Disease Control and Prevention 
(CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment (CHAC) has scheduled a public meeting. 
Information about CHAC can be found at https://www.cdc.gov/maso/facm/facmCHACHSPT.html.

DATES: March 5, 2020, 3:00 p.m.--4:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held by webinar and will accommodate up 
to 100 attendees. To access the virtual meeting, please use the 
information below.
     Webinar link: https://hrsa.connectsolutions.com/chac_business_meeting/
     Conference call-in number:
    [cir] Call in: 888-790-1964.
    [cir] Passcode: 1251991.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Public Health 
Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-5807; or [email protected].

SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of 
the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as 
amended.
    The purpose of CHAC is to advise the Secretary of HHS, the Director 
of CDC, and the HRSA Administrator regarding objectives, strategies, 
policies, and priorities for HIV, viral hepatitis, and other STDs; 
prevention and treatment efforts including surveillance of HIV 
infection, viral hepatitis, other STDs, and related behaviors; 
epidemiologic, behavioral, health services, and laboratory research on 
HIV, viral hepatitis, and other STDs; identification of policy issues 
related to HIV/viral hepatitis/STD professional eduction, patient 
healthcare delivery, and prevention services; agency policies about 
prevention of HIV, viral hepatitis and other STDs; treatment, 
healthcare delivery, and research and training; strategic issues 
influencing the ability of CDC and HRSA to fulfill their missions of 
providing prevention and treatment services; programmatic efforts to 
prevent and treat HIV, viral hepatitis, and other STDs; and support to 
the agencies in their developoment of responses to emerging health 
needs related to HIV, viral hepatitis, and other STDs.
    During the March 5, 2020, meeting, CHAC will discuss issues related 
to a CDC pilot on recency assay-based incidence estimation and the 
President's initiative on ``Ending the HIV Epidemic: A Plan for 
America.'' Agenda items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments, 
although written comments may be submitted prior to the meeting, or up 
to 5 business days after the meeting, to Theresa Jumento at the contact 
information listed above. Individuals who plan to attend and need 
special assistance or another reasonable accommodation should notify 
Theresa Jumento at the address and phone number listed above at least 
10 business days prior to the meeting.

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020-01809 Filed 1-30-20; 8:45 am]
 BILLING CODE 4165-15-P